AMETEK's financials remain solid with low leverage and efficient working capital. Click here to find out why AME stock is a ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology ...

If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering ...

Trial data showed the drug dramatically reduced cancer progression risk in certain patients, supporting Celcuity’s plans to ...

Trump’s EU trade deal exposes the media’s April tariff freakout—predictions of empty shelves, recession, and market collapse ...

Third, Vertex still has an exciting pipeline in CF and elsewhere. For instance, the company's late-stage candidate for APOL-1 ...

After an initial sigh of relief at the U.S. and European Union avoiding further escalation by striking a trade agreement, concerns have grown that the framework deal is "unbalanced" and leaves Europe ...

Under the framework deal struck by European Commission president Ursula von der Leyen and Trump at his Turnberry golf resort ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Agreement allows educational institutions to access cold chain packaging solutions without the typical request for proposal ...

As new pricing and trade policies take shape, 60% of life sciences and healthcare executives anticipate business disruption, ...